First Trust Multi-Manager Small Cap Opportunities ETF(MMSC.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
First Trust Multi-Manager Small Cap Opportunities ETF
MMSC.US
News
View More

BUZZ-Stifel hikes defense firm Kratos' PT on strong drone orders; shares rise

Stifel has raised the price target for Kratos Defense & Security Solutionsfrom $112 to $134, maintaining a "buy" rating. This new target represents a 13.7% upside from the stock's last close. The increase is attributed to strong orders for the Valkyrie drone and advancements in hypersonic programs. KTOS shares rose nearly 2% to about $120 in premarket trading. The brokerage noted Northrop Grumman's selection of KTOS's Valkyrie for the USMC program as a sign of confidence in the company's cost-effective and reliable solutions. 15 of 18 brokerages rate KTOS as "buy" or higher, with a median price target of $100.

Reuters·
US
KTOS
+4.95%
Reuters·
US
KTOS
+4.95%

U.S. stock market midday update: MACOM Technology rises 11.32%, new board appointment and industry strength boost stock price

MACOM Technology Solutions Holdings rose 11.32%; NVIDIA rose 0.73%, with a transaction volume of $13.8 billion; Micron Technology rose 0.04%, with a transaction volume of $4.767 billion; AMD rose 2.98%, with a transaction volume of $3.808 billion; TSMC rose 2.05%, with a market capitalization of $1.71 trillion

Tracking Unusual Activity·
US
MTSI
+0.80%
Tracking Unusual Activity·
US
MTSI
+0.80%

Guardant Health (GH) Valuation Check After TRICARE Coverage Win For Shield Blood Test

Guardant Health (GH) has gained attention following TRICARE's decision to cover its Shield blood test for colorectal cancer screening for military members and families in Florida. The stock has seen a 90-day return of 76.1% and a 1-year return of 189.16%. Analysts suggest a fair value of $118, indicating the stock may be undervalued at its current price of around $110. However, risks include high R&D costs and potential underwhelming payer adoption. Investors are encouraged to explore other healthcare stocks and opportunities.

Simplywall·
US
GH
+0.14%
Simplywall·
US
GH
+0.14%

Has Karman Holdings (KRMN) Run Too Far After NYSE Listing And Rapid Share Price Surge?

Karman Holdings (KRMN) has seen a significant share price surge, rising 38.4% in the past week and 58.9% over the last month, currently priced at approximately US$101.28. However, a Discounted Cash Flow analysis suggests it is overvalued by 283.7%, with an intrinsic value estimated at US$26.40 per share. Additionally, its Price-to-Sales ratio stands at 31.29x, far exceeding industry averages, indicating a rich valuation. Analysts express caution, highlighting potential risks and the need for a deeper understanding of the company's financial health and future cash flow projections.

Simplywall·
US
KRMN
-0.90%
Simplywall·
US
KRMN
-0.90%

Trump's record $15 trillion military spending to fight a "world war"? Defense stocks rebound significantly, drone manufacturers surge by double digits

Trump stated that the U.S. military budget for fiscal year 2027 should be raised to $1.5 trillion, which is an increase of over 50% compared to this year's budget. On Thursday, Lockheed Martin's stock rose over 9%, and drone company Kratos saw a 20% increase. American media personnel believe that Trump's increase in military spending indicates that the U.S. may be preparing for a "world war," and a budget of $1.5 trillion reflects "the characteristics of a country preparing for global or regional warfare." Although there is uncertainty regarding this military spending, analysts generally agree that the direction of U.S. defense spending growth is clear

Wallstreetcn·
US
KTOS
+4.95%
Wallstreetcn·
US
KTOS
+4.95%
© 2026 Longbridge｜Disclaimer